Jill
Furman
Leadership Role
Acting
Director - Office of Compliance
![Jill Furman, J.D.](https://public4.pagefreezer.com:443/content/FDA/23-02-2023T11:18/https://www.fda.gov/files/styles/person_portrait_large/public/Jill-Furman-acting-director-office-of-compliance.jpg?itok=sXGef_vp)
Jill Furman, J.D., serves as the Acting Director of the Office of Compliance in the Center for Drug Evaluation and Research (CDER). The Office of Compliance is charged with protecting the public from poor quality, unsafe, and ineffective drug products through proactive compliance strategies and risk-based enforcement actions.
Ms. Furman joined FDA in 2020 as the Office of Compliance Deputy Director after more than 22 years with the U.S. Department of Justice’s (DOJ) Consumer Protection Branch, where she handled a wide range of consumer protection matters, including civil and criminal litigation under the Food, Drug, and Cosmetic Act. In her last 8 years at DOJ, Ms. Furman served as the Deputy Director of that office, supervising litigation, and providing leadership and direction to attorneys and staff.
Before joining DOJ, Ms. Furman served as an Assistant District Attorney with the Suffolk County District Attorney’s Office in Boston, Massachusetts, where she prosecuted criminal cases in state appellate and trial courts.
Ms. Furman earned her law degree from Boston University School of Law and her bachelor’s degree from the University of Pennsylvania.